Magen Daniella
Pediatric Nephrology Institute, Rambam Health Care Campus, Technion Faculty of Medicine, Haifa, Israel.
Harefuah. 2017 Oct;156(10):654-658.
Hereditary disorders of renal phosphate handling comprise a diverse group of genetic diseases, usually characterized by excessive urinary phosphate wasting and a negative phosphate balance. In the minority of cases, perturbations of renal phosphate handling are associated with excessive urinary phosphate reabsorption, leading to pathological hyperphosphatemia. Inorganic phosphate is an essential mineral in the human body, playing a crucial role in cellular metabolism and skeletal mineralization. Whole body phosphate balance is maintained by a highly controlled equilibrium between intestinal uptake, skeletal deposition and renal excretion. The human kidney plays a crucial role in phosphate homeostasis. The bulk filtered phosphate is reabsorbed in the renal proximal tubule by two specialized phosphate transporters, NaPi-IIa and NaPi-IIc. Phosphate balance is regulated by dietary phosphate intake, and by the action of the parathyroid hormone, vitamin D3 and fibroblast growth factor-23 (FGF-23). All these regulators exert their effect by modulating the activity of the proximal-tubular phosphate transporters, NaPi-IIa and NaPi-IIc. Based on the versatile molecular mechanism underlying various renal phosphate wasting disorders, these diseases can be divided into three main subgroups: (1) primary impairment of proximal tubular phosphate transporters; (2) disorders of FGF-23 metabolism; (3) generalized dysfunction of the proximal tubule, also known as renal Fanconi syndrome. The clinical similarity between various renal phosphate wasting disorders, combined with their rarity, pose a diagnostic and therapeutic challenge. Recent advancement in molecular biology has led to the identification of the genetic basis of many disorders in this group, has improved our understanding of underlying disease mechanisms, and enables accurate genetic diagnosis. Nevertheless, the current therapy of most renal phosphate wasting disorders is mainly supportive, with limited capacity to change their natural course.
遗传性肾性磷代谢紊乱包括多种遗传性疾病,通常表现为尿磷过度流失和负磷平衡。在少数情况下,肾性磷代谢紊乱与尿磷重吸收过多有关,导致病理性高磷血症。无机磷是人体必需的矿物质,在细胞代谢和骨骼矿化中起关键作用。全身磷平衡通过肠道吸收、骨骼沉积和肾脏排泄之间高度受控的平衡来维持。人类肾脏在磷稳态中起关键作用。大部分滤过的磷通过两种特殊的磷转运体NaPi-IIa和NaPi-IIc在近端肾小管中重吸收。磷平衡受饮食中磷摄入量以及甲状旁腺激素、维生素D3和成纤维细胞生长因子-23(FGF-23)的作用调节。所有这些调节因子都通过调节近端肾小管磷转运体NaPi-IIa和NaPi-IIc的活性发挥作用。基于各种肾性磷流失疾病背后的多种分子机制,这些疾病可分为三个主要亚组:(1)近端肾小管磷转运体原发性损害;(2)FGF-23代谢紊乱;(3)近端肾小管普遍功能障碍,也称为肾范科尼综合征。各种肾性磷流失疾病之间的临床相似性,加上它们的罕见性,对诊断和治疗构成了挑战。分子生物学的最新进展已导致确定了该组中许多疾病的遗传基础,增进了我们对潜在疾病机制的理解,并能够进行准确的基因诊断。然而,目前大多数肾性磷流失疾病的治疗主要是支持性的,改变其自然病程的能力有限。